Last reviewed · How we verify
Cephalosporins and Macrolide Antibiotics — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Cephalosporins and Macrolide Antibiotics (Cephalosporins and Macrolide Antibiotics) — Beijing Children's Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Cephalosporins and Macrolide Antibiotics TARGET | Cephalosporins and Macrolide Antibiotics | Beijing Children's Hospital | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Cephalosporins and Macrolide Antibiotics CI watch — RSS
- Cephalosporins and Macrolide Antibiotics CI watch — Atom
- Cephalosporins and Macrolide Antibiotics CI watch — JSON
- Cephalosporins and Macrolide Antibiotics alone — RSS
Cite this brief
Drug Landscape (2026). Cephalosporins and Macrolide Antibiotics — Competitive Intelligence Brief. https://druglandscape.com/ci/cephalosporins-and-macrolide-antibiotics. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab